Blood Metabolites May Serve as Kidney Function Indicators
By LabMedica International staff writers Posted on 19 Oct 2015 |
A nontargeted metabolomics approach in which gas and liquid chromatography were coupled to mass spectrometry was used to quantify 493 small molecules in human serum and relate them to changes in kidney function due to chronic kidney disease (CKD).
Metabolomics is the study of chemical processes involving metabolites, while the metabolome represents the collection of all metabolites in a biological cell, tissue, organ, or organism that are the end products of cellular processes. Changes in serum metabolite concentrations may result from impaired kidney function and can be used to estimate the glomerular filtration rate (GFR), an indicator of kidney performance.
Investigators at the University of Freiburg (Germany) used a combination of gas and liquid chromatography coupled to mass spectrometry to quantify small molecules in human serum. They reported finding six metabolites in the blood that had strong correlations with kidney function. In addition, two of the metabolites, pseudouridine and C-mannosyltryptophan, were equally good measures of kidney function and disease progression in patients with CKD compared with the routinely measured creatinine. However, creatinine only starts to become elevated after 50% of the kidneys’ function has already been lost.
“These markers therefore represent promising candidates to further improve the estimation of kidney function by combining them with information on creatinine concentrations. This will facilitate an improved diagnosis of CKD, enabling treatment and prevention of complications,” said senior author Dr. Anna Köttgen, a researcher in the department of nephrology at the University of Freiburg.
Details of the method for detection of kidney function metabolites in the blood were published in the October 8, 2015, online edition of the Journal of the American Society of Nephrology.
Related Links:
University of Freiburg
Metabolomics is the study of chemical processes involving metabolites, while the metabolome represents the collection of all metabolites in a biological cell, tissue, organ, or organism that are the end products of cellular processes. Changes in serum metabolite concentrations may result from impaired kidney function and can be used to estimate the glomerular filtration rate (GFR), an indicator of kidney performance.
Investigators at the University of Freiburg (Germany) used a combination of gas and liquid chromatography coupled to mass spectrometry to quantify small molecules in human serum. They reported finding six metabolites in the blood that had strong correlations with kidney function. In addition, two of the metabolites, pseudouridine and C-mannosyltryptophan, were equally good measures of kidney function and disease progression in patients with CKD compared with the routinely measured creatinine. However, creatinine only starts to become elevated after 50% of the kidneys’ function has already been lost.
“These markers therefore represent promising candidates to further improve the estimation of kidney function by combining them with information on creatinine concentrations. This will facilitate an improved diagnosis of CKD, enabling treatment and prevention of complications,” said senior author Dr. Anna Köttgen, a researcher in the department of nephrology at the University of Freiburg.
Details of the method for detection of kidney function metabolites in the blood were published in the October 8, 2015, online edition of the Journal of the American Society of Nephrology.
Related Links:
University of Freiburg
Latest Clinical Chem. News
- 3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models
- POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection
- Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases
- New Blood Testing Method Detects Potent Opioids in Under Three Minutes
- Wireless Hepatitis B Test Kit Completes Screening and Data Collection in One Step
- Pain-Free, Low-Cost, Sensitive, Radiation-Free Device Detects Breast Cancer in Urine
- Spit Test Detects Breast Cancer in Five Seconds
- Electrochemical Sensors with Next-Generation Coating Advances Precision Diagnostics at POC
- First-Of-Its-Kind Handheld Device Accurately Detects Fentanyl in Urine within Seconds
- New Fluorescent Sensor Array Lights up Alzheimer’s-Related Proteins for Earlier Detection
- Automated Mass Spectrometry-Based Clinical Analyzer Could Transform Lab Testing
- Highly Sensitive pH Sensor to Aid Detection of Cancers and Vector-Borne Viruses
- Non-Invasive Sensor Monitors Changes in Saliva Compositions to Rapidly Diagnose Diabetes
- Breakthrough Immunoassays to Aid in Risk Assessment of Preeclampsia
- Urine Test for Monitoring Changes in Kidney Health Markers Can Predict New-Onset Heart Failure
- AACC Releases Comprehensive Diabetes Testing Guidelines